Daclizumab Subcutaneous and Hydrocodone and chlorpheniramine polistirex
Determining the interaction of Daclizumab Subcutaneous and Hydrocodone and chlorpheniramine polistirex and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: chlorpheniramine / hydrocodone
Brand name: TussiCaps, Tussionex PennKinetic, S-T Forte 2, HyTan, Novasus, Vituz
Synonyms: Chlorpheniramine and hydrocodone, Hydrocodone and Chlorpheniramine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Hydrocodone and Chlorpheniramine Solution
- Daclizumab Subcutaneous-Hydrocodone and Guaifenesin
- Daclizumab Subcutaneous-Hydrocodone and Guaifenesin Oral Solution
- Daclizumab Subcutaneous-Hydrocodone and Guaifenesin Tablets
- Daclizumab Subcutaneous-Hydrocodone and homatropine
- Daclizumab Subcutaneous-Hydrocodone and Homatropine Syrup
- Hydrocodone and chlorpheniramine polistirex-Dacogen
- Hydrocodone and chlorpheniramine polistirex-Dacomitinib
- Hydrocodone and chlorpheniramine polistirex-Dactinomycin
- Hydrocodone and chlorpheniramine polistirex-Dactinomycin Injection
- Hydrocodone and chlorpheniramine polistirex-Dactinomycin Intravenous
- Hydrocodone and chlorpheniramine polistirex-Daklinza